These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 5094163)

  • 1. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of tybamate in psychotic patients. (A further double blind study).
    Meshel E; Denber HC
    Dis Nerv Syst; 1968 Apr; 29(4):243-5. PubMed ID: 4870945
    [No Abstract]   [Full Text] [Related]  

  • 3. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 5. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.
    Clare G; Simeon J; Fink M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Unexpected therapeutic effects of tybamate in psychoses].
    Turns D; Denber HC; Turns CN
    Ann Med Psychol (Paris); 1968 Jul; 2(2):216-20. PubMed ID: 5684178
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum cortisol in chronic schizophrenia. Changes in the diurnal rhythm and psychiatric mental status on withdrawal of drugs.
    Franzĕn G
    Psychiatr Clin (Basel); 1971; 4(4):237-46. PubMed ID: 5134459
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K; Fullerton AG; Hussain K; Tarlo L
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract]   [Full Text] [Related]  

  • 10. Tybamate--a perplexing drug.
    Rickels K; Hesbacher P; Vandervort W; Phillips F; Hutchison J; Sablosky L; Lavan D
    Am J Psychiatry; 1968 Sep; 125(3):76-82. PubMed ID: 4875386
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 12. A preliminary study of SKF-14,336 in chronic schizophrenia.
    Simpson GM; Iqbal J; Iqbal F
    Curr Ther Res Clin Exp; 1966 Sep; 8(9):447-51. PubMed ID: 4957931
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 14. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 15. Lithium combined with neuroleptics in the treatment of chronic schizophrenia.
    Kellams JJ; Small JG; Milstein V; Perex HC
    Psychopharmacol Bull; 1976 Apr; 12(2):27-30. PubMed ID: 769024
    [No Abstract]   [Full Text] [Related]  

  • 16. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in gustatory acuity and hyperarousal in schizophrenia.
    Fischer R; Ristine LP; Wisecup P
    Biol Psychiatry; 1969 Jul; 1(3):209-18. PubMed ID: 4390893
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.